$345.65 Million in Sales Expected for Quaker Chemical Corp (NYSE:KWR) This Quarter

Wall Street brokerages forecast that Quaker Chemical Corp (NYSE:KWR) will report $345.65 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Quaker Chemical’s earnings. The highest sales estimate is $356.00 million and the lowest is $335.30 million. Quaker Chemical reported sales of $222.02 million in the same quarter last year, which indicates a positive year over year growth rate of 55.7%. The business is scheduled to report its next quarterly earnings report on Thursday, November 7th.

On average, analysts expect that Quaker Chemical will report full-year sales of $1.18 billion for the current year, with estimates ranging from $1.15 billion to $1.21 billion. For the next financial year, analysts anticipate that the firm will report sales of $1.67 billion, with estimates ranging from $1.61 billion to $1.71 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Quaker Chemical.

Quaker Chemical (NYSE:KWR) last released its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported $1.56 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.56. Quaker Chemical had a return on equity of 18.35% and a net margin of 6.69%. The company had revenue of $205.87 million for the quarter, compared to analyst estimates of $223.15 million. During the same quarter in the prior year, the firm posted $1.56 EPS. Quaker Chemical’s quarterly revenue was down 7.2% compared to the same quarter last year.



Several research firms recently weighed in on KWR. ValuEngine lowered Quaker Chemical from a “buy” rating to a “hold” rating in a report on Friday, August 16th. Janney Montgomery Scott upgraded Quaker Chemical from a “neutral” rating to a “buy” rating in a research note on Friday, June 7th. Finally, Zacks Investment Research lowered Quaker Chemical from a “hold” rating to a “sell” rating in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Quaker Chemical presently has a consensus rating of “Hold” and a consensus target price of $193.00.

In other Quaker Chemical news, CEO Michael F. Barry sold 3,834 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $159.02, for a total value of $609,682.68. Following the sale, the chief executive officer now owns 156,301 shares in the company, valued at $24,854,985.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 2.90% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. grew its position in shares of Quaker Chemical by 0.5% during the 2nd quarter. BlackRock Inc. now owns 1,914,617 shares of the specialty chemicals company’s stock worth $388,437,000 after buying an additional 9,512 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Quaker Chemical by 36.4% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,426,977 shares of the specialty chemicals company’s stock worth $289,505,000 after buying an additional 380,431 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Quaker Chemical by 3.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 742,144 shares of the specialty chemicals company’s stock worth $145,750,000 after buying an additional 22,997 shares in the last quarter. Northern Trust Corp grew its position in shares of Quaker Chemical by 0.9% during the 2nd quarter. Northern Trust Corp now owns 185,978 shares of the specialty chemicals company’s stock worth $37,731,000 after buying an additional 1,658 shares in the last quarter. Finally, Copeland Capital Management LLC grew its position in shares of Quaker Chemical by 21.3% during the 2nd quarter. Copeland Capital Management LLC now owns 165,914 shares of the specialty chemicals company’s stock worth $33,660,000 after buying an additional 29,122 shares in the last quarter. Institutional investors and hedge funds own 99.45% of the company’s stock.

NYSE:KWR traded up $0.72 during midday trading on Tuesday, hitting $169.24. 2,380 shares of the company traded hands, compared to its average volume of 97,239. The firm’s fifty day moving average is $165.59 and its 200-day moving average is $192.12. Quaker Chemical has a 12-month low of $149.09 and a 12-month high of $224.30. The firm has a market capitalization of $2.23 billion, a P/E ratio of 28.36, a P/E/G ratio of 2.48 and a beta of 1.55. The company has a current ratio of 2.69, a quick ratio of 2.07 and a debt-to-equity ratio of 0.07.

Quaker Chemical Company Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company's products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

Further Reading: S&P 500 Index

Get a free copy of the Zacks research report on Quaker Chemical (KWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quaker Chemical (NYSE:KWR)

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.